Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

ROCHE DIAGNOSTICS

Filed by DS2 GROUP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 2, 2026
Income
$30,000.00
Expenses
Not reported
Registrant
DS2 GROUP, LLC
Filing UUID
6a7a350a-ea76-409a-9a95-39b5b2e4b3c7
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Ensuring Patient Access to Critical Breakthrough Products Act; HR 5269: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act

Literal federal measure citations: HR 5269

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.